Zacks: Brokerages Expect Humana Inc (HUM) to Post $3.21 EPS
Wall Street brokerages forecast that Humana Inc (NYSE:HUM) will report earnings of $3.21 per share for the current fiscal quarter, according to Zacks Investment Research. Six analysts have made estimates for Humana’s earnings, with estimates ranging from $3.18 to $3.25. Humana reported earnings of $2.75 per share during the same quarter last year, which suggests a positive year-over-year growth rate of 16.7%. The firm is scheduled to issue its next earnings report on Wednesday, May 2nd.
On average, analysts expect that Humana will report full year earnings of $13.95 per share for the current financial year, with EPS estimates ranging from $13.73 to $14.90. For the next year, analysts forecast that the business will report earnings of $16.47 per share, with EPS estimates ranging from $15.51 to $17.50. Zacks’ EPS calculations are a mean average based on a survey of research analysts that cover Humana.
Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, February 7th. The insurance provider reported $2.06 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $2.00 by $0.06. The company had revenue of $13.19 billion during the quarter, compared to analyst estimates of $13.14 billion. Humana had a net margin of 4.55% and a return on equity of 16.13%. Humana’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period last year, the business earned $2.34 EPS.
Shares of Humana (NYSE:HUM) traded up $0.79 during trading on Monday, hitting $270.59. 663,987 shares of the company traded hands, compared to its average volume of 1,121,635. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.85 and a current ratio of 1.85. The company has a market cap of $38,540.00, a price-to-earnings ratio of 15.37, a price-to-earnings-growth ratio of 1.46 and a beta of 0.95. Humana has a 52 week low of $203.48 and a 52 week high of $293.35.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 27th. Shareholders of record on Friday, March 30th will be paid a dividend of $0.50 per share. This is a positive change from Humana’s previous quarterly dividend of $0.40. This represents a $2.00 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Wednesday, March 28th. Humana’s dividend payout ratio (DPR) is currently 9.09%.
Humana announced that its board has authorized a share repurchase plan on Thursday, December 14th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the insurance provider to purchase shares of its stock through open market purchases. Stock buyback plans are often an indication that the company’s board believes its shares are undervalued.
In other news, VP Timothy S. Huval sold 1,382 shares of the firm’s stock in a transaction dated Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the sale, the vice president now owns 11,557 shares of the company’s stock, valued at approximately $2,843,484.28. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider M Todoroff Christopher sold 16,389 shares of the firm’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $273.37, for a total transaction of $4,480,260.93. Following the sale, the insider now directly owns 13,447 shares in the company, valued at approximately $3,676,006.39. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 40,579 shares of company stock valued at $10,842,942. 0.80% of the stock is owned by company insiders.
Hedge funds and other institutional investors have recently made changes to their positions in the company. Certified Advisory Corp purchased a new stake in shares of Humana during the 4th quarter valued at about $109,000. Fieldpoint Private Securities LLC purchased a new stake in shares of Humana during the 3rd quarter valued at about $115,000. American Beacon Advisors Inc. purchased a new stake in shares of Humana during the 4th quarter valued at about $122,000. ClariVest Asset Management LLC purchased a new stake in shares of Humana during the 3rd quarter valued at about $144,000. Finally, YorkBridge Wealth Partners LLC boosted its holdings in shares of Humana by 99.0% during the 4th quarter. YorkBridge Wealth Partners LLC now owns 597 shares of the insurance provider’s stock valued at $159,000 after acquiring an additional 297 shares during the last quarter. 96.84% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION WARNING: “Zacks: Brokerages Expect Humana Inc (HUM) to Post $3.21 EPS” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another site, it was illegally stolen and republished in violation of United States & international trademark and copyright laws. The original version of this news story can be viewed at https://www.watchlistnews.com/zacks-brokerages-expect-humana-inc-hum-to-post-3-21-eps/1910030.html.
Humana Company Profile
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.